Investors / Dexcom Ventures
Dexcom Ventures
Corporate VC
Dexcom Ventures is the venture capital platform of Dexcom, the diabetes care technology company. It invests in technology platforms adjacent to or related to Dexcom's core strategy, aiming to advance development into other chronic health conditions beyond diabetes.
Invests inHealthcare & Biotech
In its own wordsbiosensingdigital healthdiabetesremote patient monitoringmedical devicescybersecurity
Your fit with Dexcom Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsDexcom Ventures lists 6 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Growth, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 75% of its companies are based in United States. It invests most often alongside Anzu Partners, CU Healthcare Innovation Fund and Catalyst Health Ventures.
Counts come from funding rounds that name Dexcom Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundDexcom Ventures does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 0% |
| Growth | 100% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 8th | 6 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 89th | 17% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Anzu Partners | 1 |
| CU Healthcare Innovation Fund | 1 |
| Catalyst Health Ventures | 1 |
| Courtside Ventures | 1 |
| Dolby Family Ventures | 1 |
| Eniac Ventures | 1 |
| GV | 1 |
| Genoa Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers6100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Dexcom Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Dexcom Ventures| Date | Company | Stage |
|---|---|---|
| 27 May 2026 | Series C+ |
Round details for Dexcom Ventures
Amounts, full round histories and every co-investor in Dexcom Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
6 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Beta Bionics develops an insulin delivery system that automatically learns and adapts to a user's needs | Healthcare & Biotech | Portfolio page | ||
| BioIntelliSense develops and provides continuous patient monitoring solutions, including wearable devices and software for analyzing vital signs and biometric measurements. | Healthcare & Biotech | Portfolio page | ||
| Epitel develops and provides a remote EEG monitoring system called REMI | Healthcare & Biotech | Portfolio page | ||
| Medcrypt helps medical device manufacturers with cybersecurity submissions for FDA approval | Healthcare & Biotech | Portfolio page | ||
| Nutromics develops a lab-on-a-patch technology for continuous molecular monitoring | Healthcare & Biotech | Portfolio page | ||
| Signos provides continuous glucose monitoring for weight management | Healthcare & Biotech | May 2026Series C+ | Page + round |
About this data
site last read 5 Nov 2026- Site
- dexcomventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 27 May 2026
- Companies checked
- 6
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Dexcom Ventures' profile as data
Pull Dexcom Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/dexcomventures.com
# also
GET /v1/firms/dexcomventures.com/portfolio
GET /v1/firms/dexcomventures.com/coinvestors
GET /v1/firms/dexcomventures.com/news